Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russo, D.
Right arrow Articles by De Nicola, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russo, D.
Right arrow Articles by De Nicola, L.

Journal of the American Society of Nephrology, Vol 6, 1451-1458, Copyright © 1995 by American Society of Nephrology


REGULAR ARTICLES

Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure

D Russo, R Minutolo, B Cianciaruso, B Memoli, G Conte and L De Nicola
Department of Nephrology, School of Medicine, I, University of Naples, Italy.

The pathophysiology and prevention of contrast media (CM)-induced nephropathy in chronic renal failure (CRF) are still ill defined. GFR, RPF, endothelin-1 (ET-1) levels, urinary sodium concentration, and fractional excretion of sodium were measured in CRF patients undergoing water diuresis in basal conditions and 20 to 120 min after an iv bolus of either the high-osmolar CM diatrizoate (D) or the low-osmolar CM iopamidol (I). The two CM induced an immediate and progressive decline of both GFR and RPF in the absence of hypovolemia, more pronounced in D (-36% at 120 min) than after I (-19% at 120 min; P < 0.05 versus D). Both CM determined a marked and steady increase of the fractional excretion of sodium. The natriuresis could not be totally ascribed to a CM-induced osmotic diuresis as because the urinary sodium concentration markedly increased. In two further groups of patients receiving D, we studied the effects of pretreatment with a single dose of either captopril or nifedipine. Both drugs, although not preventing the increase of natriuresis, partially antagonized D-induced renal hypoperfusion: GFR and RPF were equally reduced by 20% in D/captopril and D/nifedipine (P < 0.05 versus D). In unpretreated patients receiving either D or I, plasma ET-1 did not change but urinary levels increased; these changes were, however, dissociated from those observed in renal hemodynamics. Both plasma and urinary levels of ET-1 did not vary in pretreated groups. The 72-h follow-up evidenced a significant reduction of renal function only in the unpretreated D group. Therefore, the main findings after CM administration in CRF patients are: (1) an immediate GFR decline proportional to the osmolarity of CM and secondary to the renal hypoperfusion that is neither caused by hypovolemia nor mediated by ET-1, (2) an early tubular dysfunction at the level of the proximal nephron, and (3) a protective effect of single-dose pretreatment with either captopril or nifedipine on D- induced acute and short-term GFR changes.


This article has been cited by other articles:


Home page
JAMAHome page
S. S. Brar, A. Y.-J. Shen, M. B. Jorgensen, A. Kotlewski, V. J. Aharonian, N. Desai, M. Ree, A. I. Shah, and R. J. Burchette
Sodium Bicarbonate vs Sodium Chloride for the Prevention of Contrast Medium-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Randomized Trial
JAMA, September 3, 2008; 300(9): 1038 - 1046.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
N. Pannu, N. Wiebe, M. Tonelli, and for the Alberta Kidney Disease Network
Prophylaxis Strategies for Contrast-Induced Nephropathy
JAMA, June 21, 2006; 295(23): 2765 - 2779.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
I. Goldenberg and S. Matetzky
Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies
Can. Med. Assoc. J., May 24, 2005; 172(11): 1461 - 1471.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. Kancha, J. Lee, Z. Ahmed, A. S. Kashyap, K. P. Anand, S. Kashyap, F. Jacobs, J. P. Forman, P. Ferrari, B. Vogt, et al.
Hemofiltration and the Prevention of Radiocontrast-Agent-Induced Nephropathy
N. Engl. J. Med., February 19, 2004; 350(8): 836 - 838.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Fishbane, J. H. Durham, K. Marzo, and M. Rudnick
N-Acetylcysteine In The Prevention Of Radiocontrast-Induced Nephropathy
J. Am. Soc. Nephrol., February 1, 2004; 15(2): 251 - 260.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. C. Curhan
Prevention of Contrast Nephropathy
JAMA, February 5, 2003; 289(5): 606 - 608.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. P. Leyssac, N.-H. Holstein-Rathlou, and O. Skott
Renal blood flow, early distal sodium, and plasma renin concentrations during osmotic diuresis
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1268 - R1276.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP